What's new
This page tells you about updates and recent information added to CancerHelp UK. There is information about
In October 2009 we relaunched CancerHelp UK. All the content is still here. We've just reorganised it so that you can find it more easily. We had to do this because the amount of content we have has grown by at least 4 times since we last redesigned in 2000.
All the development was done alongside consultation with our main groups of visitors - people who have cancer, relatives and friends and health professionals. There is a guide to our site in the help section. Please do send us your feedback, telling us what you like and what you don't.
In January 2012, we added a section about other treatments, which includes information about
- Radiofrequency ablation (RFA)
- Laser treatment
- High frequency focused ultrasound (HIFU)
- Photodynamic therapy (PDT)
- Cryotherapy
We also added pages about rare types of neuroendocrine tumours (NETS), including
In November 2011, we added information about
In October 2011, we added information about
In September 2011, we added information about
- Abiraterone (Zytiga) hormone therapy
- Exercises after breast cancer surgery – a video in the after surgery for breast cancer section
- Breathing and circulation exercises after surgery videos
- Breathing techniques for breathlessness video
In August 2011, we added information about
- Ipilimumab (Yervoy) biological therapy
- Nelarabine (Atriance) chemotherapy
- Nilotinib biological therapy
- Cabazitaxel chemotherapy
In July 2011, we added information about
If there are any major developments, publications of guidance from the National Institute for Health and Clinical Excellence (NICE), or clinical guidelines, we amend the relevant sections on different types of cancer, and other relevant sections, at the time. As well as this ad hoc updating, CancerHelp UK sections are reviewed and updated every 12 to 18 months.
In January 2012, we updated the
In December 2011, we updated the
In October 2011, we updated the
In September 2011, we updated the
In August 2011, we updated the
- Soft tissue sarcoma section
- Chronic myeloid leukaemia section
- Womb (endometrial and uterine) cancer section
In July 2011, we updated the
In June 2011, we updated the
In January 2012, we updated the
- Coping with mouth problems section
- Glossary
- Biological therapy section
- Mortgages, pensions and insurance section
In December 2011, we updated the
- Cancer and sickness section (nausea)
- Cancer and pain control section
- About cancer section
- Ulcerating cancers section
In October 2011, we updated the
- Genes and inherited cancer risk section
- Spinal cord compression section
- Bone marrow and stem cell transplants section
- Aloe page in the complementary therapy section
- Ayurvedic medicine in the complementary therapy section
In August 2011, we updated the
In July 2011, we updated the
In June 2011, we updated the
We are making every effort to extend and maintain our clinical trials database. This work is ongoing and by the end of January 2012 we had 417 trials listed that are open to patients in the UK. We aim to provide as comprehensive a listing of UK clinical trials in cancer care as we can. We would welcome your feedback on the clinical trials database. Click on 'feedback' at the top of any page and send us your views.
In January 2012 the following trials were added to our clinical trials database
- A study looking at giving a biological therapy as well as combined chemotherapy and radiotherapy before surgery for cancer of the back passage (XERXES)
- A trial comparing gemcitabine and vandetanib with gemcitabine alone in pancreatic cancer (ViP)
- A trial looking at giving extra white blood cells after a mini transplant (ProT4)
- A study using a questionnaire to improve the quality of life of people with lung cancer - QTIP
- A study to understand more about quality of life in people with myelodysplastic syndromes
- A trial of BYL719 for advanced solid tumours with a change to the PIK3CA gene
- A study to find activity in the immune system in early breast cancer
- A study looking at a new way of detecting early signs of lymphoedema after breast cancer surgery
- A study looking at the effect pemetrexed has on non small cell lung cancer cells
- A study looking at how common anxiety and depression are in men having active surveillance for prostate cancer
- A study looking at giving extra support for older people having chemotherapy
- A trial of IMA901 with sunitinib for advanced renal cell cancer
- A study looking at magnetic resonance imaging (MRI) scans to assess Hodgkin's lymphoma in children and young people - MELT
- A study to find out more about symptoms and experiences that young women have before being diagnosed with cancer of the cervix
- A study to find out more about coughing in people with lung cancer (CLiC study)
- A trial looking at trastuzumab and pertuzumab for HER2 positive breast cancer - APHINITY
- A trial comparing TKI258 with sorafenib in kidney cancer
- A study testing a questionnaire to work out the care needs of people using a supportive or palliative care service in Sheffield (SPARC feasibility)
- A study looking at the experiences of women with advanced ovarian cancer (ADVOCATE)
Below is a list of the most recent NHS guidance we have added to the site. NICE stands for National Institute for Health and Clinical Excellence. NICE look at the evidence on new treatments and procedures and publish guidelines for use on the NHS in England. The Scottish Medicines Consortium (SMC) and the All Wales Medicines Strategy Group (AWMSG) are the equivalent bodies for advising the NHS in Scotland and Wales.
There is a page about NICE and what they do and a separate one about the SMC in our cancer treatment QandA section.
In January 2012, we added SMC guidance on
And AWMSG guidance on
And NICE guidance on
- Fulvestrant for the treatment of locally advanced or metastatic breast cancer
- Panitumumab with chemotherapy for first line treatment of metastatic bowel cancer
In November 2011, we added SMC guidance on
In September 2011, we added NICE guidance on
And AWMSG guidance on
And SMC guidance on
In August 2011, we added NICE guidance on
And SMC guidance on
- Adjuvant capecitabine and oxaliplatin for stage 3 colorectal cancer
- Mifamurtide (Mepact) and combination chemotherapy for high grade osteosarcoma which has been removed with surgery
In July 2011, we added NICE guidance on
- Selective internal radiation therapy for non resectable colorectal metastases in the liver
- Ambulight photodynamic therapy for the treatment of non melanoma skin cancer
- Thalidomide and bortezomib for first line treatment of multiple myeloma
- Rituximab maintenance therapy for non Hodgkin's lymphoma
And SMC guidance on
In April 2011, we added SMC guidance on
We added NICE guidance on
In March 2011, we added NICE guidance on
And SMC guidance on
We are able to answer your questions about cancer. You can ring Cancer Research UK's team of experienced cancer information nurses on 020 7061 8355 or freephone 0808 800 4040. If you prefer, you can send them a question about cancer by using our question form. Please note, we cannot answer enquiries from overseas.
You can send us your views about our website via our feedback form.
Remember to include your email address in these forms. We have set up our feedback forms so that you can contact us anonymously, but if you want a personal reply you must type in your email address.
You can now search our questions and answers section. There are over 700 'questions and answers' to choose from....
Increase text
Decrease text
Print this page
